Enhanced expression of neuropeptides in human breast cancer cell lines following irradiation.
Previously, we have observed that the expression of the neuropeptides bombesin (BN-), the mammalian counterpart being gastrin-releasing peptide (GRP), and substance P (SP) in intact normal tissues, such as salivary and laryngeal glands, increases in response to irradiation. In the present study, the aim was to evaluate whether irradiation can have effects on individual cells that normally synthesize neuropeptides. In addition, since these neuropeptides are potentially mitogenic, we studied tumor cells. Therefore, the estrogen receptor-negative human breast cancer cell line MDA-MB-231 and its subline, with acquired doxorubicin resistance, MDA-MB-231 Dox were examined before irradiation and 4, 10, and 15 days after irradiation with 4 Gy (195 kV, 2 Gy fractions with 4 hours interval). Potential dose related changes were studied by delivering single doses of 2 or 9 Gy with the same technique. Immunohistochemical and radioimmunoassay (RIA) methods were used for detection of the SP and BN/GRP. Before, and at all time points following irradiation, a subpopulation in both cell lines displayed an intense immunostaining of SP and BN/GRP. A partial reorganization of the immunoreactive material was observed 10 days after irradiation. The RIA-analyses displayed signs of a dose-related increase, and a time-dependent transient and significant increase in the content of both peptides. The pattern of changes differed between the two peptides, and was especially pronounced in the doxorubicin resistant cells with regard to SP. Another neuropeptide, calcitonin gene related peptide (CGRP), was not detected in the cells used. The results suggest that irradiation has effects on a population of cultured neuropeptide-synthesizing cells. The occurrence and the specific changes obtained in the levels of neuropeptides, in response to irradiation, might imply an importance in the growth of breast cancer cells and in explaining repair processes following irradiation.
Aalto
Y
Y
Department of Oncology, Umeå University, Sweden.
Forsgren
S
S
Kjörell
U
U
Bergh
J
J
Franzén
L
L
Henriksson
R
R
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001839:Bombesin / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000532:radiotherapy*; D002455:Cell Division / Q000528:radiation effects; D004307:Dose-Response Relationship, Radiation; D004317:Doxorubicin / Q000494:pharmacology; D004351:Drug Resistance; D005260:Female; D019886:Gastrin-Releasing Peptide / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D009479:Neuropeptides / Q000378:metabolism*; D011863:Radioimmunoassay; D013373:Substance P / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects
D000903:Antibiotics, Antineoplastic; D009479:Neuropeptides; D013373:Substance P; D019886:Gastrin-Releasing Peptide; D004317:Doxorubicin; D001839:Bombesin